Adherence to adjuvant endocrine therapy after breast cancer in Sweden – a nationwide cohort study in 1-, 3- and 5-year survivors with a focus on regional differences
Despite guidelines being national, there were significant differences in adherence between regions in Sweden. As the largest differences were between age groups invited and not invited to mammography screening intervention should focus on women < 40 and ≥ 75 years at diagnosis. Further studies are needed to find strategies to increase overall adherence to AET in early BC.
Authors
- Anna De Jong (ORCID: https://orcid.org/0000-0002-3103-8170)
- Anne Andersson (ORCID: https://orcid.org/0000-0002-9597-6465)
- Lennarth Nyström (ORCID: https://orcid.org/0000-0002-5095-3454)
- Anna von Wachenfeldt (ORCID: https://orcid.org/0000-0002-3335-9787)
Institutions
- Karolinska Institutet (SE)
- Stockholm South General Hospital (SE)
- Umeå University (SE)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2024-11-24
- DOI
- https://doi.org/10.2340/1651-226x.2024.40575
- Citations
- 3
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 1.51
Funders
- Umeå Universitet